Drug Manufacturers - Specialty & Generic
Compare Stocks
2 / 10Stock Comparison
TLRY vs SMG
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Inputs
TLRY vs SMG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Agricultural Inputs |
| Market Cap | $660M | $3.62B |
| Revenue (TTM) | $1.17B | $3.35B |
| Net Income (TTM) | $-2.95B | $90M |
| Gross Margin | 28.0% | 31.0% |
| Operating Margin | -266.0% | 11.7% |
| Forward P/E | — | 14.2x |
| Total Debt | $451M | $2.38B |
| Cash & Equiv. | $304M | $37M |
TLRY vs SMG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | 100 | 57.5 | -42.5% |
| The Scotts Miracle-… (SMG) | 100 | 43.7 | -56.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TLRY vs SMG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TLRY is the clearest fit if your priority is growth exposure.
- Rev growth 4.8%, EPS growth -6.5%, 3Y rev CAGR 12.5%
- 4.8% revenue growth vs SMG's -3.9%
- +12.1% vs SMG's +20.7%
SMG carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 1.10, yield 4.2%
- 34.9% 10Y total return vs TLRY's -74.7%
- Lower volatility, beta 1.10, current ratio 1.27x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.8% revenue growth vs SMG's -3.9% | |
| Quality / Margins | 2.7% margin vs TLRY's -252.6% | |
| Stability / Safety | Beta 1.10 vs TLRY's 2.03 | |
| Dividends | 4.2% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +12.1% vs SMG's +20.7% | |
| Efficiency (ROA) | 2.9% ROA vs TLRY's -100.6%, ROIC 13.3% vs -66.2% |
TLRY vs SMG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TLRY vs SMG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SMG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SMG is the larger business by revenue, generating $3.4B annually — 2.9x TLRY's $1.2B. SMG is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to TLRY's -2.5%. On growth, TLRY holds the edge at +3.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.2B | $3.4B |
| EBITDAEarnings before interest/tax | -$3.0B | $466M |
| Net IncomeAfter-tax profit | -$2.9B | $90M |
| Free Cash FlowCash after capex | -$94M | $358M |
| Gross MarginGross profit ÷ Revenue | +28.0% | +31.0% |
| Operating MarginEBIT ÷ Revenue | -2.7% | +11.7% |
| Net MarginNet income ÷ Revenue | -2.5% | +2.7% |
| FCF MarginFCF ÷ Revenue | -8.1% | +10.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.0% | -15.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +70.7% | -78.5% |
Valuation Metrics
TLRY leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $660M | $3.6B |
| Enterprise ValueMkt cap + debt − cash | $806M | $6.0B |
| Trailing P/EPrice ÷ TTM EPS | -0.17x | 25.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.23x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 13.75x |
| Price / SalesMarket cap ÷ Revenue | 0.59x | 1.06x |
| Price / BookPrice ÷ Book value/share | 0.25x | — |
| Price / FCFMarket cap ÷ FCF | — | 13.22x |
Profitability & Efficiency
SMG leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), SMG scores 7/9 vs TLRY's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -136.5% | — |
| ROA (TTM)Return on assets | -100.6% | +2.9% |
| ROICReturn on invested capital | -66.2% | +13.3% |
| ROCEReturn on capital employed | -78.1% | +17.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.22x | — |
| Net DebtTotal debt minus cash | $147M | $2.3B |
| Cash & Equiv.Liquid assets | $304M | $37M |
| Total DebtShort + long-term debt | $451M | $2.4B |
| Interest CoverageEBIT ÷ Interest expense | -89.43x | 3.08x |
Total Returns (Dividends Reinvested)
TLRY leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TLRY five years ago would be worth $3,498 today (with dividends reinvested), compared to $3,094 for SMG. Over the past 12 months, TLRY leads with a +1209.3% total return vs SMG's +20.7%. The 3-year compound annual growth rate (CAGR) favors TLRY at 26.7% vs SMG's -1.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -41.8% | +6.1% |
| 1-Year ReturnPast 12 months | +1209.3% | +20.7% |
| 3-Year ReturnCumulative with dividends | +103.6% | -3.2% |
| 5-Year ReturnCumulative with dividends | -65.0% | -69.1% |
| 10-Year ReturnCumulative with dividends | -74.7% | +34.9% |
| CAGR (3Y)Annualised 3-year return | +26.7% | -1.1% |
Risk & Volatility
SMG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SMG is the less volatile stock with a 1.10 beta — it tends to amplify market swings less than TLRY's 2.03 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SMG currently trades 86.2% from its 52-week high vs TLRY's 36.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.03x | 1.10x |
| 52-Week HighHighest price in past year | $15.70 | $72.35 |
| 52-Week LowLowest price in past year | $0.35 | $52.00 |
| % of 52W HighCurrent price vs 52-week peak | +36.1% | +86.2% |
| RSI (14)Momentum oscillator 0–100 | 37.9 | 48.9 |
| Avg Volume (50D)Average daily shares traded | 4.7M | 938K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates TLRY as "Hold" and SMG as "Buy". Consensus price targets imply 76.7% upside for TLRY (target: $10) vs 15.4% for SMG (target: $72). SMG is the only dividend payer here at 4.21% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $10.00 | $72.00 |
| # AnalystsCovering analysts | 20 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | +4.2% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $2.63 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.5% |
SMG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TLRY leads in 2 (Valuation Metrics, Total Returns).
TLRY vs SMG: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is TLRY or SMG a better buy right now?
For growth investors, Tilray Brands, Inc.
(TLRY) is the stronger pick with 4. 8% revenue growth year-over-year, versus -3. 9% for The Scotts Miracle-Gro Company (SMG). The Scotts Miracle-Gro Company (SMG) offers the better valuation at 25. 3x trailing P/E (14. 2x forward), making it the more compelling value choice. Analysts rate The Scotts Miracle-Gro Company (SMG) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — TLRY or SMG?
Over the past 5 years, Tilray Brands, Inc.
(TLRY) delivered a total return of -65. 0%, compared to -69. 1% for The Scotts Miracle-Gro Company (SMG). Over 10 years, the gap is even starker: SMG returned +34. 9% versus TLRY's -74. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — TLRY or SMG?
By beta (market sensitivity over 5 years), The Scotts Miracle-Gro Company (SMG) is the lower-risk stock at 1.
10β versus Tilray Brands, Inc. 's 2. 03β — meaning TLRY is approximately 84% more volatile than SMG relative to the S&P 500.
04Which is growing faster — TLRY or SMG?
By revenue growth (latest reported year), Tilray Brands, Inc.
(TLRY) is pulling ahead at 4. 8% versus -3. 9% for The Scotts Miracle-Gro Company (SMG). On earnings-per-share growth, the picture is similar: The Scotts Miracle-Gro Company grew EPS 504. 9% year-over-year, compared to -651. 7% for Tilray Brands, Inc.. Over a 3-year CAGR, TLRY leads at 12. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — TLRY or SMG?
The Scotts Miracle-Gro Company (SMG) is the more profitable company, earning 4.
3% net margin versus -266. 3% for Tilray Brands, Inc. — meaning it keeps 4. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMG leads at 10. 5% versus -277. 9% for TLRY. At the gross margin level — before operating expenses — SMG leads at 30. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is TLRY or SMG more undervalued right now?
Analyst consensus price targets imply the most upside for TLRY: 76.
7% to $10. 00.
07Which pays a better dividend — TLRY or SMG?
In this comparison, SMG (4.
2% yield) pays a dividend. TLRY does not pay a meaningful dividend and should not be held primarily for income.
08Is TLRY or SMG better for a retirement portfolio?
For long-horizon retirement investors, The Scotts Miracle-Gro Company (SMG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
10), 4. 2% yield). Tilray Brands, Inc. (TLRY) carries a higher beta of 2. 03 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SMG: +34. 9%, TLRY: -74. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between TLRY and SMG?
These companies operate in different sectors (TLRY (Healthcare) and SMG (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: TLRY is a small-cap quality compounder stock; SMG is a small-cap income-oriented stock. SMG pays a dividend while TLRY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.